Apple Watch sales in the first half of 2025 are expected to be about 10% higher than expected.
New information shows that the outlook for the third quarter is very promising, although the electronics market is affected by tariffs and the global economy.
In addition to the Apple Intelligence-based features in watchOS 26, the Apple Watch Series 11 (with Apple Watch Ultra 3) may be added with a blood pressure measurement feature.
In the early stages, the blood pressure measurement feature was expected to only track trends and unusual warnings, similar to how Apple previously introduced the temperature tracking feature.
Notably, according to supply chain sources, the 2026 Apple Watch will have three highlights: doubled sensors; Changed exterior design; Significantly improved energy performance.
Despite the rumors that the high-end Apple Watch will be completely redesigned, it is likely that Apple will still keep the rounded sensor cluster at the bottom, even if the number of sensors doubles.
If the information is correct, 2026 could become an important milestone for Apple Watch, bringing many new medical sensors and design innovations.
In the context of an increasingly competitive wearables market, a strategy to promote health features and improve user experience can help Apple strengthen its leading position.
From the Series 11 with blood pressure measurement to the 2026 generation with a new double sensor and design, the Apple Watch is gradually moving towards the goal of becoming the most trusted individual health assistant on users wrists.
